MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.amjmed.2017.09.007

Медицинская библиотека · The American journal of medicine · 2017

Is 30-Day Mortality after Admission for Heart Failure an Appropriate Metric for Quality?

Faillace Robert T, Yost Gregory W, Chugh Yashasvi, Adams Jeffrey, Verma Beni R, Said Zaid, Sayed Ibrahim Ismail, Honushefsky Ashley, Doddamani Sanjay, Berger Peter B

СтатьяПеревод в очереди

Аннотация

BACKGROUND

The Centers for Medicare and Medicaid Services (CMS) model for publicly reporting national 30-day-risk-adjusted mortality rates for patients admitted with heart failure fails to include clinical variables known to impact total mortality or take into consideration the culture of end-of-life care. We sought to determine if those variables were related to the 30-day mortality of heart failure patients at Geisinger Medical Center.

METHODS

Electronic records were searched for patients with a diagnosis of heart failure who died from any cause during hospitalization or within 30 days of admission.

RESULTS

There were 646 heart-failure-related admissions among 530 patients (1.2 admissions/patient). Sixty-seven of the 530 (13%) patients died: 35 (52%) died during their hospitalization and 32 (48%) died after discharge but within 30 days of admission; of these, 27 (40%) had been transferred in for higher-acuity care. Fifty-one (76%) died from heart failure, and 16 (24%) from other causes. Fifty-five (82%) patients were classified as American Heart Association Stage D, 58 (87%) as New York Heart Association Class IV, and 30 (45%) had right-ventricular systolic dysfunction. None of the 32 patients who died after discharge met recommendations for beta-blockers. Criteria for prescribing angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and mineralocorticoid receptor blockers were not met by 33 of the 34 patients (97%) with heart failure with reduced ejection fraction not on one of those drugs. Fifty-seven patients (85%) had a do-not-resuscitate (DNR) status.

CONCLUSION

A majority of heart failure-related mortality was among patients who opted for a DNR status with end-stage heart failure, limiting the appropriateness of administering evidence-based therapies. No care gaps were identified that contributed to mortality at our institution. The CMS 30-day model fails to take important variables into consideration.

Для цитирования: Faillace Robert T, Yost Gregory W, Chugh Yashasvi, Adams Jeffrey, Verma Beni R, Said Zaid, Sayed Ibrahim Ismail, Honushefsky Ashley, Doddamani Sanjay, Berger Peter B. Is 30-Day Mortality after Admission for Heart Failure an Appropriate Metric for Quality?. The American journal of medicine. 2017. DOI: 10.1016/j.amjmed.2017.09.007.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.